TY  - GEN
AU  - Dominguez, Fernando
AU  - Climent, Vicente
AU  - Zorio, Esther
AU  - Ripoll-Vera, Tomás
AU  - Salazar-Mendiguchia, Joel
AU  - Manuel Garcia-Pinilla, Jose
AU  - Angel Urbano-Moral, Jose
AU  - Fernandez-Fernandez, Xusto
AU  - Lopez-Cuenca, David
AU  - Ajo-Ferrer, Raquel
AU  - Sanz-Sanchez, Jorge
AU  - Gomez-Perez, Yolanda
AU  - Lopez-Garrido, Miguel A
AU  - Barriales-Villa, Roberto
AU  - Ramon Gimeno, Juan
AU  - Garcia-Pavia, Pablo
PY  - 2017
DO  - 10.1016/j.ijcard.2017.08.010
SN  - 0167-5273
UR  - http://hdl.handle.net/20.500.12105/20494
AB  - Background: Chronic anticoagulation with vitamin K antagonists (VKAs) is recommended in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF). Direct oral anticoagulants (NOACs) are an alternative to VKAs but there are limited...
LA  - eng
PB  - Elsevier
KW  - Hypertrophic cardiomyopathy
KW  - Atrial fibrillation
KW  - Anticoagulation
KW  - Aged
KW  - Administration, Oral
KW  - Follow-Up Studies
KW  - Humans
KW  - Cardiomyopathy, Hypertrophic
KW  - Middle Aged
KW  - Longitudinal Studies
KW  - Male
KW  - Atrial Fibrillation
KW  - Female
KW  - Cohort Studies
KW  - Anticoagulants
KW  - Retrospective Studies
TI  - Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
TY  - research article
ER  -